The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication ...
Zepbound helps aid weightloss. Research consistently suggests people with overweight or obesity have more average weightloss on Zepbound than a placebo. The active ingredient in ...